# Proteomic Approach Using Matrix-assisted Laser Desorption/Ionization Tandem Time-of-flight (MALDI-TOF/TOF) of Tumor Response in Rectal Carcinoma After Radiochemotherapy

> **NCT00855946** · — · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 46 (actual)

## Conditions studied

- Rectal Adenocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00855946
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2013-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00855946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00855946, "Proteomic Approach Using Matrix-assisted Laser Desorption/Ionization Tandem Time-of-flight (MALDI-TOF/TOF) of Tumor Response in Rectal Carcinoma After Radiochemotherapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00855946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*